ESBRIET
HOFFMANN-LA ROCHE LIMITED
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is ESBRIET discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that ESBRIET 267MG has been permanently discontinued (last updated August 3, 2023). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Why is ESBRIET not available?
The reason the manufacturer reported: Business reasons.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
SANDOZ PIRFENIDONE CAPSULES
SANDOZ CANADA INCORPORATED
Other Products
JAMP PIRFENIDONE
JAMP PHARMA CORPORATION
SANDOZ PIRFENIDONE TABLETS
SANDOZ CANADA INCORPORATED
AURO-PIRFENIDONE
AURO PHARMA INC
TEVA-PIRFENIDONE
TEVA CANADA LIMITED
MAR-PIRFENIDONE
MARCAN PHARMACEUTICALS INC
What this means
Does this mean I need to switch medications right away?
Not necessarily right away, but this product will not be returning to the market.
What should I do?
Talk to your pharmacist or prescriber about your options well before your current supply runs out.
DIN
02393751
Strength
267MG
Dosage Form
CAPSULE
Route
ORAL
Compare with another product →
Shortage History
Other Products from HOFFMANN-LA ROCHE LIMITED
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
162MG · DIN 02424770
80MG · DIN 02350092
162MG · DIN 02483327
400MG · DIN 02350114
200MG · DIN 02350106
DIN 02225689
DIN 02147440
150MG · DIN 02458136
25MG · DIN 02270994
2MG · DIN 02245859
200MG · DIN 02242145
250MG · DIN 02192748